To evaluate the usefulness of nifedipine for the treatment of pulmonary hypertension, the effects of nifedipine on pulmonary hemodynamics and gas exchange were studied in 36 patients with chronic pulmonary disease.
The patients were divided into two groups. Non PH group: 18 patients with pulmonary arterial mean pressure (Ppa)<20 Torr. PH group: 18 patients with Ppa≥20 Torr. Cardiac catheterization was performed with a Swan-Ganz catheter and cardiac output was measured by the thermodilution method. The femoral artery was cannulated with a lung water catheter for blood gas sampling and pressure monitoring, and pulmonary extravascular thermal volume (ETV) was measured by the double indicator dilution method using heat and dye.
After baseline hemodynamic and gas exchange measurements were made, the patients were given 10mg of nifedipine sublingually, and after 20min, the same measurements were repeated and compared with the changes after 100% oxygen inhalation.
After administration of nifedipine, C. I. increased and Pao and total peripheral vascular resistance had fallen significantly in both groups, but Ppa was almost unchanged and pulmonary arteriolar resistance (PAR) had fallen significantly only in the PH group. PaO
2 decreased but PvO
2 and O
2 transport increased in both groups. In the nonPH group, the ETV was unchanged, but in the PH group, it significantly increased from 6.76±0.47 to 7.46±0.35ml/kg.
The PAR change after nifedipine showed significant correlation with that after 100% oxygen inhalation (r=0.73), so, it was suggested that nifedipine inhibits hypoxic pulmonary vascoconstriction. In addition, the PAR change after nifedipine showed significant correlation with baseline PAR value (r=0.89).
Therefore, nifedipine was thought to be useful for vasodilator therapy in chronic pulmonary disease with pulmonary hypertension.
View full abstract